Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Implantable Cardioverter Defibrillators (ICD) Pipeline Market Report Overview

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. The ICD pipeline market research report provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

ICD Pipeline Market Segments

The key segments in the ICD pipeline market are Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD). In 2023, both the segments have equal number of pipeline products.

ICD Pipeline Market Segmentation by Territories

Some of the key territories in the ICD pipeline market are the US, Europe, China, Israel, Japan, South Korea, Taiwan, India, Mexico, and New Zealand. In 2023, the US has the highest number of pipeline products.

ICD Pipeline Market Analysis, by Territories, 2023 (%)

ICD Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the ICD pipeline market, download a free report sample

ICD Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the ICD pipeline market are PMA, CE, NMPA, Shonin, BOPA, NIFDS, TGA, HAS, ICAC, and MDL. In 2023, PMA was the most followed regulatory path for pipeline products.

ICD Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

ICD Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory paths into the ICD pipeline market, download a free report sample

ICD Pipeline Market- Competitive Landscape

Some of the key companies in the ICD pipeline market are Advanced BioInformatics GmbH, AIS Inc., Arrhythmia Dynamics LLC, AtaCor Medical Inc, Boston Scientific Corp, CardiaLen, Inc., Coridea, LLC, Impulse Dynamics Germany GmbH, InnerPulse Inc (Inactive), and Johns Hopkins University.

Arrhythmia Dynamics LLC: Arrhythmia Dynamics LLC (Arrhythmia Dynamics) focuses on smart defibrillator algorithm for treatment of cardiac arrhythmias. Arrhythmia Dynamics is headquartered in Madison, Connecticut, the US.

AtaCor Medical Inc: AtaCor Medical Inc, is a medical device company that designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing. The company is headquartered in United States.

Boston Scientific Corp: Headquartered in Marlborough, Massachusetts, the US, Boston Scientific Corp (Boston Scientific) is a medical technology company that is involved in the development, manufacturing and commercialization of devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery.

ICD Pipeline Market Report Overview

Key Territories The US, Europe, China, Israel, Japan, South Korea, Taiwan, India, Mexico, New Zealand, Singapore, Costa Rica, El Salvador, Australia, and Canada
Key Segments Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD)
Key Regulatory Paths PMA, CE, NMPA, Shonin, BOPA, NIFDS, TGA, HAS, ICAC, and MDL
Leading Companies Advanced BioInformatics GmbH, AIS Inc., Arrhythmia Dynamics LLC, AtaCor Medical Inc, Boston Scientific Corp, CardiaLen, Inc., Coridea, LLC, Impulse Dynamics Germany GmbH, InnerPulse Inc (Inactive), and Johns Hopkins University

Segments Covered in the Report

ICD Pipeline Market Segments Outlook

  • Single Chamber Implantable Cardioverter Defibrillators (ICD)
  • Subcutaneous Implantable Cardioverter Defibrillators (ICD)

ICD Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Israel
  • Japan
  • South Korea
  • Taiwan
  • India
  • Mexico
  • New Zealand
  • Singapore
  • Costa Rica
  • El Salvador
  • Australia
  • Canada

ICD Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • Shonin
  • BOPA
  • NIFDS
  • TGA
  • HAS
  • ICAC
  • MDL

Scope

  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
  • Reviews of major players involved in the pipeline product development.
  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Implantable Cardioverter Defibrillators (ICD) pipeline products.
  • Review of Recent Developments in the segment / industry

Reasons to Buy

The Implantable Cardioverter Defibrillators (ICD) report enables you to:

  • Access significant competitor information, analysis, and insights to improve your R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development.
  • Formulate market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

Advanced BioInformatics GmbH
AIS Inc.
Arrhythmia Dynamics LLC
AtaCor Medical Inc
Boston Scientific Corp
CardiaLen, Inc.
Coridea, LLC
Impulse Dynamics Germany GmbH
InnerPulse Inc (Inactive)
Johns Hopkins University
Kenergy Inc.
Massachusetts General Hospital
Max Planck Institute for Dynamics and Self-Organization
Medicool Technologies Inc
Medtronic Inc
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
Smartwave Medical Ltd (Inactive)
University of Chicago

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Implantable Cardioverter Defibrillators (ICD) Overview

  • 3 Products under Development

    • 3.1 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development
    • 3.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment
    • 3.3 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory
    • 3.4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path
    • 3.5 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date
    • 3.6 Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials

  • 4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products under Development by Companies

    • 4.1 Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development
    • 4.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development

  • 5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview

    • 5.1 Advanced BioInformatics GmbH Company Overview

      • 5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 AIS Inc. Company Overview

      • 5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Arrhythmia Dynamics LLC Company Overview

      • 5.3.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 AtaCor Medical Inc Company Overview

      • 5.4.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Boston Scientific Corp Company Overview

      • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 CardiaLen, Inc. Company Overview

      • 5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Coridea, LLC Company Overview

      • 5.7.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Impulse Dynamics Germany GmbH Company Overview

      • 5.8.1 Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 InnerPulse Inc (Inactive) Company Overview

      • 5.9.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Johns Hopkins University Company Overview

      • 5.10.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Kenergy Inc. Company Overview

      • 5.11.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Massachusetts General Hospital Company Overview

      • 5.12.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Max Planck Institute for Dynamics and Self-Organization Company Overview

      • 5.13.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Medicool Technologies Inc Company Overview

      • 5.14.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Medtronic Inc Company Overview

      • 5.15.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Medtronic Plc Company Overview

      • 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 MicroPort CRM SA Company Overview

      • 5.17.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 MicroPort Scientific Corp Company Overview

      • 5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Smartwave Medical Ltd (Inactive) Company Overview

      • 5.19.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 University of Chicago Company Overview

      • 5.20.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments

    • 6.1 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.2 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
    • 6.3 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
    • 6.4 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
    • 6.5 Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
    • 6.6 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
    • 6.7 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
    • 6.8 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.9 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.10 Nov 17, 2022: Mindray North America unveils new true to life vital signs monitor
    • 6.11 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.12 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
    • 6.13 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
    • 6.14 Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
    • 6.15 Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split
    • 6.16 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges
    • 6.17 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
    • 6.18 Oct 12, 2022: Philips provides update on its financial performance in Q3 2022
    • 6.19 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.20 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.21 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.22 Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer
    • 6.23 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
    • 6.24 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
    • 6.25 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders
    • 6.26 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.27 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes
    • 6.28 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.29 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • 6.30 May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
    • 6.31 May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results
    • 6.32 May 04, 2022: Conmed Announces First Quarter 2022 Financial Results
    • 6.33 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
    • 6.34 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 9

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 10

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 11

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 12

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 13

Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 14

Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development 15

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 16

Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 17

Cardiac Rhythm Management Device – Product Status 17

Cardiac Rhythm Management Device – Product Description 17

AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Guardian – Product Status 18

Guardian – Product Description 18

Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview 19

IntelliSync ICD Control Algorithm – Product Status 19

IntelliSync ICD Control Algorithm – Product Description 19

AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

EV-ICD Lead – Product Status 20

EV-ICD Lead – Product Description 20

AtaCor Medical Inc – Ongoing Clinical Trials Overview 21

EV-ICD Lead – Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study 22

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 23

S-ICD System 1.5 – Product Status 23

S-ICD System 1.5 – Product Description 23

Vitality Nxt Defibrillator – Product Status 24

Vitality Nxt Defibrillator – Product Description 24

CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25

MultiPulse Therapy Device – Product Status 25

MultiPulse Therapy Device – Product Description 25

CardiaLen, Inc. – Ongoing Clinical Trials Overview 26

MultiPulse Therapy Device – Study Evaluating the Safety and Efficacy of MultiPulse Therapy in an Acute Clinical Setting 27

Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 28

Table-Top PaDe System – Product Status 28

Table-Top PaDe System – Product Description 28

Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview 29

Optimizer Integra – Product Status 29

Optimizer Integra – Product Description 29

InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

PICD – Product Status 30

PICD – Product Description 30

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 31

Cardiac Sock Electrode And Implantable Defibrillator System – Product Status 31

Cardiac Sock Electrode And Implantable Defibrillator System – Product Description 31

Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

Unconditional MRI Compatible Implantable Defibrillator – Product Status 32

Unconditional MRI Compatible Implantable Defibrillator – Product Description 32

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 33

Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Status 33

Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Description 33

Vagal Stimulation ICD Device – Product Status 34

Vagal Stimulation ICD Device – Product Description 34

Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 35

Implantable Defibrillator – Product Status 35

Implantable Defibrillator – Product Description 35

Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Implantable Defibrillator – Product Status 36

Implantable Defibrillator – Product Description 36

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 37

LUMINA EV-ICD – Product Status 37

LUMINA EV-ICD – Product Description 37

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 38

Aurora EV-ICD Extravascular Defibrillation System – Product Status 38

Aurora EV-ICD Extravascular Defibrillation System – Product Description 39

Chronicle ICD – Product Status 39

Chronicle ICD – Product Description 39

Medtronic Plc – Ongoing Clinical Trials Overview 40

Aurora EV-ICD Extravascular Defibrillation System – Extravascular ICD Pilot Study 41

Aurora EV-ICD Extravascular Defibrillation System – Extravascular ICD Pivotal Study: EV ICD 41

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 42

Edis – Non-MRI ICD – Product Status 42

Edis – Non-MRI ICD – Product Description 42

Navigo 4LV PILOT – Product Status 43

Navigo 4LV PILOT – Product Description 43

Subcutaneous ICD – Product Status 43

Subcutaneous ICD – Product Description 44

Ulys – Non-MRI ICD – Product Status 44

Ulys – Non-MRI ICD – Product Description 44

MicroPort CRM SA – Ongoing Clinical Trials Overview 45

Navigo 4LV PILOT – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 46

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 47

ENERGYA ICD – Product Status 47

ENERGYA ICD – Product Description 47

Space HP ICD – Product Status 48

Space HP ICD – Product Description 48

Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49

Fully Automatic Implantable Atrial Defibrillator – Product Status 49

Fully Automatic Implantable Atrial Defibrillator – Product Description 49

University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 50

Implantable Cardioverter Defibrillator – Product Status 50

Implantable Cardioverter Defibrillator – Product Description 50

Glossary 84

Figures

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 9

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 10

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 11

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 12

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 13

Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 14

Frequently asked questions

Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.